Inmune Bio Files Proxy Statement for May 28th Shareholder Meeting
Ticker: INMB · Form: DEF 14A · Filed: Apr 21, 2025 · CIK: 1711754
| Field | Detail |
|---|---|
| Company | Inmune Bio, Inc. (INMB) |
| Form Type | DEF 14A |
| Filed Date | Apr 21, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, corporate-governance
TL;DR
Inmune Bio's proxy statement is out for the May 28th meeting - time to vote on directors & auditors.
AI Summary
Inmune Bio, Inc. filed a definitive proxy statement (DEF 14A) on April 21, 2025, for its annual meeting of stockholders scheduled for May 28, 2025. The filing details the company's corporate governance, executive compensation, and proposals to be voted on by shareholders. Key items likely include the election of directors and ratification of independent auditors.
Why It Matters
This filing provides shareholders with crucial information regarding company leadership, compensation, and voting matters, enabling informed participation in corporate governance decisions.
Risk Assessment
Risk Level: medium — Proxy statements are routine filings, but the specific proposals and outcomes can significantly impact a company's future direction and stock performance.
Key Numbers
- DEF 14A — Filing Type (Indicates a definitive proxy statement, a standard filing for shareholder meetings.)
Key Players & Entities
- Inmune Bio, Inc. (company) — Filer of the proxy statement
- 20250528 (date) — Date of the annual meeting of stockholders
- 20250421 (date) — Filing date of the proxy statement
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information necessary to vote at the annual meeting of stockholders, including details on director nominations, executive compensation, and other corporate matters.
When is the annual meeting of stockholders for Inmune Bio, Inc. scheduled?
The annual meeting of stockholders is scheduled for May 28, 2025.
What is the filing date of this proxy statement?
This proxy statement was filed on April 21, 2025.
What is the company's Standard Industrial Classification (SIC) code?
The company's SIC code is 2836, categorized under BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
Where is Inmune Bio, Inc. headquartered?
Inmune Bio, Inc. is headquartered at 225 NE MIZNER BLVD, SUITE 640, BOCA RATON, FL 33432.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 21, 2025 regarding Inmune Bio, Inc. (INMB).